Bone Metastases
📧 Sign up to get email alerts when something new happens for Bone Metastases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects. [Phase 3]
Phase 3 trial comparing denosumab to zoledronic acid for treating bone metastases in breast cancer; results posted after completion.
-
CLINICAL_TRIALS research · 2014-01-22Clinical Trial Update: A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease. [Phase 2]
Phase 2 study evaluating loading doses of intravenous ibandronate (Bondronat) in patients with breast cancer and malignant bone disease; the…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving Bisphosphonates [Phase 4]
Phase 4 trial update evaluating the efficacy and safety of bisphosphonates in patients with non-small cell lung cancer and bone metastases. …
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis [Phase 4]
A Phase 4 clinical trial evaluating the efficacy and safety of ZOMETA (zoledronic acid) in patients with non-small cell lung cancer with bon…
-
CLINICAL_TRIALS withdrawal · 2013-11-13Clinical Trial Update: S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone [Phase 3]
Phase 3 trial evaluating zoledronic acid or ibandronate to prevent bone problems in women with stage IV breast cancer that has spread to bon…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-09-23FDA Approved: ZOLEDRONIC ACID — Original Application (Sagent Pharmaceuticals)
FDA approves a generic zoledronic acid injection from Sagent Pharmaceuticals under ANDA 202828, granting approval to market the product for …
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Optimization of Radiotherapy in Treatment of Painful Bone Metastasis [Phase 3]
Phase 3 clinical trial evaluating optimized radiotherapy for painful bone metastases has completed.
-
FDA approval · 2013-06-28FDA Approved: SODIUM FLUORIDE F 18 — Original Application (Mayo Clinic)
The FDA approved an Original Application for Sodium Fluoride F-18, a radiopharmaceutical used for bone imaging to detect metastatic bone dis…
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: Effect of Aminobiphosphonates and Statins on Circulating Vgamma9Vdelta2-T Cells [NA]
A clinical trial evaluating the effects of aminobiphosphonates and statins on circulating Vgamma9Vdelta2-T cells in patients with bone metas…
-
FDA approval · 2013-03-29FDA Approved: ZOLEDRONIC ACID — Original Application (Dr.Reddy's Laboratories Ltd)
FDA approved the original application for Zoledronic acid (generic) from Dr. Reddy's Laboratories Ltd. This approval confirms a generic vers…
-
CLINICAL_TRIALS research · 2013-03-13Clinical Trial Update: Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer [Phase 3]
Phase 3 clinical trial comparing ibandronate versus zoledronic acid in patients with newly diagnosed bone metastases from breast cancer.
-
FDA approval · 2013-03-04FDA Approved: ZOLEDRONIC ACID — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's zoledronic acid under an original application, enabling a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets [Phase 3]
A Phase 3 clinical trial comparing F18PET/CT with TC-MDP scanning for detecting bone metastases; the study status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2012-09-17Clinical Trial Update: MR Guided Focused Ultrasound Surgery of Metastatic Bone Tumors [Phase 1]
This update covers a Phase 1 clinical trial evaluating MRI-guided focused ultrasound surgery for metastatic bone tumors. The study status is…
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: Magnetic Resonance-Guided High Intensity Focused Ultrasound for Palliation of Painful Skeletal Metastases [Phase 1, Phase 2]
This clinical trial update covers phase 1/2 results for MRI-guided high-intensity focused ultrasound used to palliate pain from bone metasta…
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates [Phase 4]
A Phase 4 trial evaluating the efficacy and tolerability of zoledronic acid in metastatic prostate cancer patients with bone metastases trea…
-
CLINICAL_TRIALS trial_result · 2012-03-02Clinical Trial Update: To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer [Phase 2]
Phase 2 clinical trial evaluating the efficacy of zoledronic acid (ZOMETA) for treating bone metastases in patients with stage IV nasopharyn…
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer [Phase 2]
A Phase 2 trial evaluating Strontium-89 with or without Cisplatin for palliation of bone pain in hormone-refractory prostate cancer with bon…
-
CLINICAL_TRIALS trial_result · 2011-12-09Clinical Trial Update: Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases [Phase 1]
Phase 1 clinical trial evaluating helical tomotherapy as a radiotherapy technique for treating bone metastases has completed. Sponsored by A…
-
FDA approval · 2011-09-23FDA Approved: TECHNETIUM TC 99M MEDRONATE — Supplemental Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)
FDA approves a supplemental application for Technetium Tc-99m medronate (Medronate) from Jubilant Radiopharma, updating labeling to reflect …
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease [Phase 2]
Phase 2 study evaluating safety and effects of saracatinib (AZD0530) in breast and prostate cancer subjects with metastatic bone disease; re…
-
CLINICAL_TRIALS trial_result · 2011-01-07Clinical Trial Update: Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer [Phase 2]
Phase 2 trial update for denosumab in bisphosphonate-naive metastatic breast cancer; the study was completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2010-12-21Clinical Trial Update: Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation [Phase 1]
A Phase 1 study assessing safety and early efficacy signals for combining radiotherapy with zoledronic acid to palliate bone metastases; con…
-
FDA approval · 2010-10-22FDA Approved: TECHNETIUM TC 99M MEDRONATE — Supplemental Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)
FDA approved a supplemental application for Technetium Tc-99m Medronate (bone imaging agent) submitted by Jubilant DraxImage Inc., dba Jubil…
-
CLINICAL_TRIALS trial_result · 2010-09-14Clinical Trial Update: Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis [Phase 2, Phase 3]
Phase 2/3 trial update reporting completion of studies evaluating zoledronic acid (Zometa) in breast cancer patients with bone metastases, i…